Screener
Roivant Sciences ROIV United States — Total deferred tax benefit
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The source filing: Roivant Sciences’s 10-K, filed May 20, 2026.
- Filed
- May 20, 2026, 7:17 AM EDT
- Fiscal year
- FY2025
- Accession
- 0001635088-26-000061
| Current taxes: / Bermuda | Years Ended March 31, 2026 / $ | Years Ended March 31, 2026 / — | Years Ended March 31, 2025 / $ | Years Ended March 31, 2025 / — | Years Ended March 31, 2024 / $ | Years Ended March 31, 2024 / — |
|---|---|---|---|---|---|---|
| Total current tax expense | $ | $133,329 | $ | $48,174 | $ | $21,503 |
| Deferred taxes: | ||||||
| Bermuda | $ | — | $ | — | $ | — |
| United States | — | — | — | |||
| Switzerland | — | — | — | |||
| Other | — | — | — | |||
| Total deferred tax benefit | $ | — | $ | — | $ | — |
| Total income tax expense | $ | $133,329 | $ | $48,174 | $ | $21,503 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Roivant Sciences's united states — total deferred tax benefit?
- Roivant Sciences (ROIV) reported united states — total deferred tax benefit of $0 in Q1 2026.
- What does united states — total deferred tax benefit mean?
- This metric reflects the recognition of future tax savings resulting from temporary differences between the book value of assets and liabilities and their tax bases within the U.S. segment. It indicates potential future reductions in cash tax payments as these temporary differences reverse. A higher benefit often signals the utilization of past losses or timing differences to offset future tax liabilities.
Ask your AI about Roivant Sciences's united states — total deferred tax benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude